Novinky
23. 8. 2021
VUOS have developed several quinolone-based intermediates for pharmaceutical use
The process was developed in laboratory and the amounts can be scale up according to customers´request. Examples of derivatives are given below:
15. 7. 2022
VUOS have developed several 1,4-disubstituted imidazole and benzimidazole intermediates for pharmaceutical use
The process was developed in laboratory and the amounts can be scale up according to customers´request. Examples of derivatives are given below:
4. 8. 2022
VUOS has developed synthesis of THICA (N, N`, N``-trihydroxyisocyanuric acid, CAS 143435-52-3)
.jpg)
- highly efficient carbon radical producing (CRPC) catalyst for radical reactions, especially oxidation
- higher catalytic activity than conventional NHPI (N-hydroxyphthalimide)
- available from grams to kilograms in stock
- larger amount on demand
Tento web používá k poskytování služeb, personalizaci reklam a analýze návštěvnosti soubory cookie. Používáním tohoto webu s tím souhlasíte.
